Cinctive Capital Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3M Buy
161,996
+88,933
+122% +$10.8M 0.64% 37
2026
Q1
$11.9M Buy
73,063
+55,118
+307% +$8.47M 0.78% 23
2025
Q4
$3.12M Sell
17,945
-48,236
-73% -$8.8M 0.17% 161
2025
Q3
$9.53M Buy
66,181
+33,307
+101% +$4.08M 0.46% 61
2025
Q2
$3.31M Buy
32,874
+9,321
+40% +$713K 0.17% 169
2025
Q1
$1.8M Sell
23,553
-1,699
-7% -$130K 0.14% 165
2024
Q4
$1.74M Sell
25,252
-5,454
-18% -$393K 0.09% 235
2024
Q3
$2.24M Sell
30,706
-114,851
-79% -$8.48M 0.12% 223
2024
Q2
$9.75M Buy
145,557
+85,294
+142% +$3.31M 0.46% 58
2024
Q1
$1.63M Sell
60,263
-114,737
-66% -$3.21M 0.08% 233
2023
Q4
$5.42M Buy
+175,000
New +$4.54M 0.36% 95

Other funds holding INSM

Cinctive Capital Management's INSM Position: Q2 2026 in Review

Cinctive Capital Management increased its Insmed (INSM) stake by 122% in Q2 2026, buying an estimated $10.8M and bringing the position to 161,996 shares worth $17.3M. The position accounts for 0.64% of the portfolio, ranked #37.

Cinctive Capital Management first reported a position in INSM in Q4 2023 and has held it in 11 quarters since. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Cinctive Capital Management held 161,996 shares of Insmed worth $17.3M as of Q2 2026.
  • Cinctive Capital Management bought 88,933 Insmed shares in Q2 2026, an estimated $10.8M.
  • Insmed made up 0.64% of Cinctive Capital Management's portfolio in Q2 2026, its #37 holding.
  • Cinctive Capital Management first reported a position in Insmed in Q4 2023 and has held it in 11 quarters since.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.